Truncated adenomatous polyposis coli (APC) tumour suppressor protein can undergo tyrosine phosphorylation

Citation
Al. Norris et al., Truncated adenomatous polyposis coli (APC) tumour suppressor protein can undergo tyrosine phosphorylation, EUR J CANC, 36(4), 2000, pp. 525-532
Citations number
28
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
EUROPEAN JOURNAL OF CANCER
ISSN journal
09598049 → ACNP
Volume
36
Issue
4
Year of publication
2000
Pages
525 - 532
Database
ISI
SICI code
0959-8049(200003)36:4<525:TAPC(T>2.0.ZU;2-5
Abstract
Numerous mutations in the adenomatous polyposis coli (APC) gene have been d escribed in colorectal cancer. The vast majority introduce nonsense codons leading to the production of truncated N-terminal APC fragments. Mutations occurring before APC codon 158, have been associated with an attenuated for m of familial adenomatous polyposis whereas those occurring at codon 168 or beyond lead to the characteristic form of the disease. These 10 amino acid residues of APC contain a YYAQ motif which appears to constitute a potenti al SH2 binding domain similar to a sequence present in tyrosine kinase rece ptors that activate STAT 3 when phosphorylated. We have expressed a recombi nant, N-terminal APC fragment in bacterial cells, and shown that it can ind eed undergo tyrosine phosphorylation in this domain. We used site-directed mutagenesis to confirm the specificity of the reaction. These observations raise the possibility that tyrosine phosphorylation may be another mechanis m involved in controlling APC function. (C) 2000 Elsevier Science Ltd. All rights reserved.